These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 26219)
41. The use of drugs for behavior modification as it relates to the practice of optometry--Part II. Koetting JF J Am Optom Assoc; 1977 Feb; 48(2):213-22. PubMed ID: 16048 [TBL] [Abstract][Full Text] [Related]
42. An update on assessment and treatment of complex attention-deficit hyperactivity disorder. Hunt RD; Paguin A; Payton K Pediatr Ann; 2001 Mar; 30(3):162-72. PubMed ID: 11257946 [No Abstract] [Full Text] [Related]
43. Conceptual issues in the use of drugs for the treatment of aggression in man. Lion JR J Nerv Ment Dis; 1975 Feb; 160(2-1):76-82. PubMed ID: 235009 [TBL] [Abstract][Full Text] [Related]
44. A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder. Wilens TE; Biederman J; Mick E; Spencer TJ J Nerv Ment Dis; 1995 Jan; 183(1):48-50. PubMed ID: 7807071 [No Abstract] [Full Text] [Related]
45. Attention deficit and hyperactivity disorder: a therapeutic option. Topczewski A Einstein (Sao Paulo); 2014 Sep; 12(3):310-3. PubMed ID: 25295451 [TBL] [Abstract][Full Text] [Related]
47. Drugs in management of minimal brain dysfunction. Millichap JG Ann N Y Acad Sci; 1973 Feb; 205():321-34. PubMed ID: 4144050 [No Abstract] [Full Text] [Related]
48. Pharmacotherapy for mental health problems in people with intellectual disability. Ji NY; Findling RL Curr Opin Psychiatry; 2016 Mar; 29(2):103-25. PubMed ID: 26779860 [TBL] [Abstract][Full Text] [Related]
49. Platelet shape change in patients with psychiatric disorders and treated with phenothiazines, thioxanthines, butyrophenones, benzodiazepines, tricyclic antidepressants and beta-adrenergic blocking agents. Boullin DJ J Neural Transm; 1981; 51(3-4):245-56. PubMed ID: 6116745 [TBL] [Abstract][Full Text] [Related]
50. Use of drugs in child psychiatry. Sitholey P Indian J Pediatr; 1984; 51(411):467-75. PubMed ID: 6151937 [No Abstract] [Full Text] [Related]
51. Principles of use of psychotropic drugs in children. Werry JS Drugs; 1979 Nov; 18(5):392-7. PubMed ID: 41701 [No Abstract] [Full Text] [Related]
52. Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report. Wood DR; Reimherr FW; Wender PH; Johnson GE Arch Gen Psychiatry; 1976 Dec; 33(12):1453-60. PubMed ID: 793563 [TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder. Markowitz JS; Patrick KS Clin Pharmacokinet; 2001; 40(10):753-72. PubMed ID: 11707061 [TBL] [Abstract][Full Text] [Related]
54. Drugs in management of hyperkinetic and perceptually handicapped children. Millichap JG JAMA; 1968 Nov; 206(7):1527-30. PubMed ID: 4386794 [No Abstract] [Full Text] [Related]
55. Chronic pain of childhood: a pharmacologic approach. Lacouture PG; Gaudreault P; Lovejoy FH Pediatr Clin North Am; 1984 Oct; 31(5):1133-51. PubMed ID: 6148730 [TBL] [Abstract][Full Text] [Related]
56. Treatment of attention deficit hyperactivity disorder: a critical review. Brown CS DICP; 1991 Nov; 25(11):1207-13. PubMed ID: 1763538 [TBL] [Abstract][Full Text] [Related]
57. Five burning questions. Zito JM J Dev Behav Pediatr; 2002 Feb; 23(1 Suppl):S23-30. PubMed ID: 11875287 [No Abstract] [Full Text] [Related]
58. Stimulants and neuroleptics in hyperactive children. Gualtieri CT; Hicks RE J Am Acad Child Psychiatry; 1985 May; 24(3):363-4. PubMed ID: 2861224 [No Abstract] [Full Text] [Related]
59. Behavioural and drug treatment of children with severe mental handicap. Corbett JA Br J Psychiatry; 1975; Spec No 9():365-70. PubMed ID: 241451 [No Abstract] [Full Text] [Related]
60. [Role of drugs in recovery from brain damage]. Vuadens P Rev Med Suisse Romande; 2000 Sep; 120(9):717-24. PubMed ID: 11094536 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]